Search for: "ELI LILLY & CO."
Results 681 - 700
of 1,009
Sort by Relevance
|
Sort by Date
26 Mar 2010, 4:15 am
Eli Lilly & Co., Fed. [read post]
25 Mar 2010, 1:43 pm
Eli Lilly & Co., 119 F.3d 1559, 1568-69 (Fed. [read post]
24 Mar 2010, 11:54 am
Eli Lilly (08-1248). [read post]
24 Mar 2010, 11:33 am
Ariad sued Eli Lilly over 6,410,516. [read post]
24 Mar 2010, 4:45 am
Eli Lilly & Co. [read post]
23 Mar 2010, 1:31 pm
Eli Lilly & Co. [read post]
23 Mar 2010, 6:00 am
Eli Lilly and Co., pp. 12, 26. [read post]
22 Mar 2010, 9:15 pm
Eli Lilly and Co. [read post]
22 Mar 2010, 8:52 pm
Eli Lilly & Co. is good law. [read post]
22 Mar 2010, 12:17 pm
Eli Lilly and Co. [read post]
22 Mar 2010, 8:44 am
Eli Lilly and Co. [read post]
18 Mar 2010, 2:30 am
(Patent Docs) (GenericsWeb) (patentcircle) Temodar (Temozolomide) – US: Teva announces parties to patent litigation regarding Barr’s US generic Temodar have entered into agreement pending resolution of Schering’s appeal to CAFC over ‘291 patent unenforceability finding (SmartBrief) Trilipix (Fenofibrate) – US: Impax Laboratories confirms challenge to Abbott and Fournier’s listed patent relating to Trilipix delayed-release capsules, 135 mg and 45 mg (SmartBrief)… [read post]
11 Mar 2010, 12:23 pm
Eli Lilly & Co., 536 F. [read post]
8 Mar 2010, 10:26 am
Some quotes:Eli Lilly and Co. has agreed to add four... [read post]
26 Feb 2010, 12:59 pm
Eli Lilly & Co. and that the Federal Circuit's forthcoming decision in that case may alter the scope and purpose of the written description requirement. [read post]
24 Feb 2010, 11:20 am
Eli Lilly & Co. has agreed to pay $18.5 million to the State of Arkansas to settle a lawsuit alleging that the company engaged in “illegal and fraudulent off-label marketing of Zyprexa,” an anti-psychotic drug. [read post]
24 Feb 2010, 6:40 am
Eli Lilly & Co., Fed. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
18 Feb 2010, 10:34 am
Because those are federal statutes, they can’t be “preempted” the way state-law claims were in Buckman Co. v. [read post]